MGF / PEG-MGF
FitnessAlso known as: Mechano Growth Factor, IGF-1Ec, Pegylated MGF
Limited EvidenceWhat is MGF / PEG-MGF?
Mechano Growth Factor (MGF) is a splice variant of IGF-1 produced locally in muscle tissue in response to mechanical strain (exercise). It activates satellite cells to repair and grow muscle. The pegylated form (PEG-MGF) has a longer half-life. Used experimentally in fitness contexts but human evidence is essentially absent.
How it works
When muscle fibers are stressed, the IGF-1 gene is alternatively spliced to produce MGF rather than systemic IGF-1. The unique C-terminal E-domain activates muscle satellite cells (stem cells for muscle repair), triggering proliferation and fusion into mature fibers. Distinct from systemic IGF-1 LR3. PEG-MGF adds polyethylene glycol chains to extend serum half-life from minutes to several hours.
What marketers claim
- ▸doubles muscle mass with minimal effort
- ▸safe alternative to steroids
- ▸works identically in humans as animals
- ▸must be used immediately after training
What evidence supports
- ✓MGF splice variant confirmed produced in human skeletal muscle in response to exercise (biopsy studies)
- ✓activates satellite cell proliferation in vitro
- ✓animal studies show increased muscle cross-sectional area with exogenous MGF
- ✓PEG-MGF extends half-life from <1 min to several hours in animal models
Research evidence
Key studies on MGF / PEG-MGF, summarized in plain language. This is not an exhaustive list — it highlights the most relevant findings.
Local IGF-1 splice variant (MGF) induces satellite cell activation and muscle hypertrophy
Finding: Plasmid-based delivery of MGF produced approximately 25% increase in muscle fiber cross-sectional area over 3 weeks in rodents without requiring satellite cell fusion for full hypertrophy.
Limitation: Rodent model; plasmid-based gene delivery is fundamentally different from synthetic peptide injection and results may not translate.
MGF in human skeletal muscle: differential expression with exercise
Finding: Biopsy data from resistance-trained humans confirmed MGF mRNA increased significantly after eccentric exercise, validating the existence of exercise-driven alternative splicing in human muscle.
Limitation: Confirms endogenous MGF production in humans but provides no data on safety or efficacy of exogenous synthetic MGF administration.
Best for
What to expect
Realistic timeline based on available research. Individual results vary.
Acute
Native MGF half-life is under 1 minute without PEGylation — rapidly degraded by serum proteases. PEG-MGF extends this to several hours, making exogenous administration more pharmacologically feasible.
Week 1–4
Animal studies show satellite cell activation within days of exogenous MGF; measurable muscle hypertrophy in rodents at 3–4 weeks with repeated dosing.
Human timeline
Unknown — no human clinical trials have been conducted to establish any efficacy or safety timeline for exogenous MGF or PEG-MGF in humans.
Safety notes & concerns
Full safety guide →- ⚠no human clinical trials demonstrating efficacy or safety
- ⚠endogenous MGF acts locally at strain site — exogenous injection may not replicate this spatial targeting
- ⚠research chemical only, no pharmaceutical-grade human product
- ⚠IGF-1 pathway stimulation has theoretical oncological concerns with long-term use
- ⚠most user reports are anecdotal with no controlled methodology
Pairs well with
Use caution with
Frequently asked questions
How is MGF different from IGF-1 LR3?
MGF is locally acting and specifically activates satellite cells at sites of mechanical damage. IGF-1 LR3 is a modified systemic form of IGF-1 that acts on multiple tissue types including muscle, liver, and fat. MGF is theoretically more muscle-specific, but this local-action advantage is based on endogenous biology — whether exogenous injection replicates local targeting is not established.
Why use PEG-MGF instead of native MGF?
Native MGF has a half-life of seconds to minutes in serum — rapidly degraded by proteases, making exogenous administration impractical. PEGylation (attaching polyethylene glycol chains) shields the peptide from enzymatic degradation and extends half-life to several hours. The trade-off is that PEGylation may alter some biological interactions and the modification changes the molecule from the naturally occurring form.
Related fitness peptides
those exploring growth hormone optimization under medical supervision
investigational GH axis optimisation in adults seeking to restore youthful GH pulsatility for recovery, sleep quality, and body composition — in a research context with physician oversight; Sermorelin is the more legally accessible clinical alternative in the US for similar goals
understanding GH secretagogue research — use under medical supervision only
research context — those exploring GH secretagogues under medical supervision
Take the Peptide Quiz
Get personalized recommendations
Stack Builder
Build a routine with MGF / PEG-MGF
Last updated: 2026-06-10
Medical Disclaimer
The information on this site is for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, or prevent any condition. Always consult with a qualified healthcare professional before starting any new supplement, peptide, or treatment protocol.